Such a prospective approach is supported by other recent studies emphasising the contribution of PIEZO1 to the development of glioma malignancy [103] and elevated expression of PIEZO1 in peritumoural brain oedema, associated with worse prognoses in glioma patients [104]. Here, PIEZO1 is linked to central nervous system cancer.